BRIACELL THERAPEUTICS CORP BCTXW
*W EXP 02/26/202 · Equity WRT · CUSIP 10778Y112
6
institutional holders
+1 vs Q1 2023
628.8k
shares reported held*
$1.6mreported value*
1 new
0 added
3 reduced
0 sold out
net sold ≈ $285.1k (-114.0k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.49.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 8 |
| Q4 2022 | 9 |
| Q1 2023 | 5 |
| Q2 2023 | 6 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 2 | 3 |
| Q1 2023 | 1 | 5 |
| Q2 2023 | 1 | 3 |
Biggest buyers
| Sequoia Financial Advisors, LLC | New | +45.0k |
Biggest sellers
| K.J. Harrison & Partners Inc | Reduced | -101.9k |
| Privium Fund Management B.V. | Reduced | -57.2k |
| ARMISTICE CAPITAL, LLC | Reduced | -1 |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| ARMISTICE CAPITAL, LLC 0.02% of their portfolio | 375.0k $937.5k | Reduced -1 |
| Redmond Asset Management, LLC 0.06% of their portfolio | 75.0k $187.5k | Unchanged |
| K.J. Harrison & Partners Inc 0.03% of their portfolio | 68.9k $171.6k | Reduced -101.9k |
| Privium Fund Management B.V. 0.05% of their portfolio | 64.9k $159.0k | Reduced -57.2k |
| Sequoia Financial Advisors, LLC 0.00% of their portfolio | 45.0k $112.5k | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |